What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons

Journal of Cardiology

Volumn 44, Issue 3, 2004, Pages 85-92

  Chino, Masao ^a   Sakamoto, Munehisa ^a   Sasaki, Toyoshi ^b   Isshiki, Takaaki ^c  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b National Hospital Organization   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary heart disease; Cost effectiveness; Interventional cardiology (percutaneous coronary intervention); Myocardial infarction, treatment; Prognosis; Stent

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BALLOON CATHETER; COMPARATIVE STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DATA BASE; FOLLOW UP; HOSPITAL COST; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; LENGTH OF STAY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVASCULARIZATION; UNIVERSITY HOSPITAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; STENTS; TREATMENT OUTCOME;

EID: 12344253309     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chino M, Nakanishi S, Isshiki T: The first nationwide database for cost analysis of percutaneous transluminal coronary angioplasty (PTCA) in Japan: Part 1. Registry and basic characteristics. Jpn J Interv Cardiol 2000; 15: 407-412 (in Jpn with Eng abstr)
2. Chino M, Nakanishi S, Isshiki T, Hashimoto H: The JSIC nationwide database for cost analysis of percutaneous transluminal coronary angioplasty (PTCA)in Japan: Part 2. Multivariate analysis of initial in-hospital charge and the inter-hospital difference. Jpn J Interv Cardiol 2001; 16: 401-407 (in Jpn with Eng abstr)
3. Sasaki T, Chino M, Isshiki T, Hasegawa T, Yamaguchi T: The JSIC nationwide database for cost analysis of percutaneous transluminal coronary angioplasty (PTCA) in Japan: Part 3. Number of events, and cumulative cost during the follow-up period. Jpn J Interv Cardiol 2002; 17: 575-579 (in Jpn with Eng abstr)
4. Ikeda S, Bosch J, Banz K, Schneller P: Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan. J Invas Cardiol 2000; 12: 194-199
5. Cohen DJ, Krumholz HM, Sukin CA, Ho KKL, Siegrist RB, Cleman M, Heuser RR, Brinker JA, Moses JW, Savage MP, Detre K, Leon MB, Baim DS, for the Stent Restenosis Study Investigators: In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Results from a randomized clinical trial. Circulation 1995; 92: 2480-2487
6. Peterson ED, Cowper PA, DeLong ER, Zidar JP, Stack RS, Mark DB : Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 1999; 33: 1610-1618
7. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MAM, van Hout BA, for the Arterial Revascularization Therapies Study Group: Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124
8. Cohen DJ, Taira DA, Berezin R, Cox DA, Morice MC, Stone GW, Grines CL, on behalf of the Stent-PAMI investigators: Cost-effectiveness of coronary stenting in acute myocardial infarction: Results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial. Circulation 2001; 104: 3039-3045
9. Chino M: Cost analysis of procedural fee for percutaneous transluminal coronary angioplasty at six Japanese hospitals. J Cardiol 2001; 37: 83-90 (in Jpn with Eng abstr)
10. Baim DS, Cutlip DE, Midei M, Linnemeier TJ, Schreiber T, Cox D, Kereiakes D, Popma JJ, Robertson L, Prince R, Lansky AJ, Ho KKI, Kuntz RE, for the ASCENT investigators (ACS MultLink Stent Clinical Equivalence in De Novo Lesions Trial): Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001; 87: 157-162
11. Serruys PW, Unger F, Van Hout BA, Van den Brand MJB, Van Herwerden LA, Van Es GA, Morel MA, Bonnier JJRM, Colombo A, Morice MC, Simon R, Wijns W, Kremer D, Mohr F, Petterson G, Santoil C, Breeman A, Vandormael M, Firth BG, Madonna O, Marshall PR, Hugenholtz PG, on behalf of the ARTS study group: The ARTS (Arterial Revascularization Therapies Study): Background, goals and methods. Int J Cardiovasc Intervent 1999; 2: 41-50
12. Cowper PA, Peterson ED, DeLong ER, Wightman MB, Wawrzynski RP, Muhlbaier LH, Sketch MH: The impact of statistical adjustment on economic profiles of interventional cardiologists. J Am Coll Cardiol 2001; 38: 1416-1423
13. Heiat A, Mattera JA, Henry GA, Chen YT, Krumholz HM: Trends in costs of percutaneous transluminal coronary angioplasty. Am J Manag Care 1998; 4: 1667-1674
14. Greenberg D, Bakhai A, Cohen DJ: Can we afford to eliminate restenosis? Can we afford not to? J Am Coll Cardiol 2004; 43: 513-518
15. Serruys PW, van Hout BV, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA, the Benestent study group: Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-681
16. Sakurai K, Watanabe J, Iwabuchi K, Koseki Y, Kon-no Y, Fukuchi M, Komaru T, Shinozaki T, Miura M, Sakuma M, Kagaya Y, Kitaoka S, Shirato K: Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: Registry of Miyagi Study Group for AMI(MsAMI). Circ J 2003; 67: 209-214